• Scientists 'one step closer' to male contraceptive pill
    Men could soon be able to take a medication to make them temporarily infertile

    Microscopy & microtechniques

    Scientists 'one step closer' to male contraceptive pill

    Researchers in Australia have made a development that could mean the male contraceptive pill is just around the corner. A reversible way of stopping sperm entering the ejaculate without any adverse effects on sexual function. 

    Rather than undergoing a temporary vasectomy to achieve the same effect, the new discovery could lead to a pharmaceutical alternative that would mean that men would only need to take a daily medication.

    Scientists from Monash University published their findings in the journal 'Proceedings of the National Academy of Sciences'. The study shows that during animal testing they were able to stop sperm being mixed with ejaculate, effectively storing it so that it could not be released.

    Previous work into the development of a contraceptive pill for men has looked at creating a medication that results in the production of sperm that does not function. However, many of the drugs that have been developed with this idea in mind have resulted in side effects that were intolerable for the subjects, according to Doctor Sabatino Ventura, one of the researchers on the study.

    Rather than creating sperm that wasn't functional, the scientists created genetically modified mice that were not able to release sperm out of the vas deferens - the storage area for sperm within the testes that the sperm goes to just before ejaculation takes place. This means that the mice were infertile although they were still able to perform sexually.

    The researchers have so far managed to alter the DNA of two mice, which has resulted in them becoming infertile by stopping them producing proteins that are needed to move sperm. They will now concentrate on finding two medications that achieve the same effect. 

    It is believed that one such medication has already been developed and has been used for a number of years to treat patients suffering from benign enlarged prostate. Work will have to begin from the start in developing the second drug, which could take a number of years. 


    Digital Edition

    Lab Asia 32.2 April

    April 2025

    Chromatography Articles - Effects of small deviations in flow rate on GPC/SEC results Mass Spectrometry & Spectroscopy Articles - Waiting for the present to catch up to the future: A bette...

    View all digital editions

    Events

    Medtec Japan 2025

    Apr 09 2025 Tokyo, Japan

    FORUMESURE

    Apr 22 2025 Hammamet, Tunisia

    Korea Lab 2025

    Apr 22 2025 Kintex, South Korea

    Analytica Anacon India & IndiaLabExpo

    Apr 23 2025 Mumbai, India

    Analitika Expo 2024

    Apr 23 2025 Moscow, Russia

    View all events

    Great Job...
    The latest issue will be with you shortly
    Sign up to Labmate for FREE.
    Register and get the eBulletin, a Monthly email packed with the latest Laboratory products, news and services. Join us and get the latest Laboratory information first.